|
NVDA
|
Technology |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$5.4T
|
$6.25
|
+0.6%
|
+1.1%
|
-0.9%
|
-4.0%
|
+3.2%
|
-1.0%
|
|
AAPL
|
Technology |
BofA Securities |
Maintains
|
Buy
→
Buy
|
—
|
$4.5T
|
$79.43
|
+0.1%
|
+0.5%
|
-0.3%
|
-2.9%
|
+2.8%
|
+2.1%
|
|
MSFT
|
Technology |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$3.1T
|
$165.70
|
+0.3%
|
+0.6%
|
-1.0%
|
-1.7%
|
+2.0%
|
+1.6%
|
|
AMZN
|
Consumer Cyclical |
Monness, Crespi, Hardt |
Maintains
|
Buy
→
Buy
|
—
|
$2.9T
|
$94.37
|
-0.1%
|
-0.1%
|
-1.2%
|
-1.8%
|
+1.4%
|
+0.3%
|
|
TSLA
|
Consumer Cyclical |
Exane BNP Paribas |
Downgrade
|
Outperform
→
Neutral
|
—
|
$1.4T
|
$37.97
|
-0.9%
|
+0.5%
|
-1.3%
|
-1.2%
|
+1.6%
|
+2.5%
|
|
MU
|
Technology |
Morgan StanleyB |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$786.1B
|
$59.17
|
+2.0%
|
+0.1%
|
-2.4%
|
-4.1%
|
+1.9%
|
-2.1%
|
|
XOM
|
Energy |
Scotiabank |
Downgrade
|
Sector Perform
→
Sector Underperform
|
—
|
$699.8B
|
$67.19
|
-0.7%
|
-0.6%
|
-0.7%
|
-2.4%
|
-0.1%
|
-0.8%
|
|
V
|
Financial Services |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$648.6B
|
$207.90
|
+0.0%
|
-0.7%
|
-0.7%
|
-1.6%
|
+0.6%
|
+1.0%
|
|
ASML
|
Technology |
RBC Capital |
Maintains
|
Outperform
→
Outperform
|
—
|
$602.8B
|
$296.25
|
+0.2%
|
-0.7%
|
+0.5%
|
-3.9%
|
+2.1%
|
+2.1%
|
|
JNJ
|
Healthcare |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$558.8B
|
$148.25
|
-0.1%
|
+0.2%
|
-0.1%
|
+0.3%
|
+0.5%
|
+0.7%
|
|
MA
|
Financial Services |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$448.7B
|
$324.31
|
+0.2%
|
+0.2%
|
-0.4%
|
-2.4%
|
+1.4%
|
+0.0%
|
|
NFLX
|
Communication Services |
Guggenheim |
Maintains
|
Buy
→
Buy
|
—
|
$385.7B
|
$32.60
|
+0.0%
|
+7.2%
|
+1.0%
|
-2.9%
|
+1.6%
|
-1.5%
|
|
CVX
|
Energy |
ScotiabankD |
Upgrade
|
Sector Perform
→
Sector Outperform
|
—
|
$366.1B
|
$112.90
|
-0.4%
|
+0.2%
|
-1.1%
|
-1.3%
|
+0.7%
|
-0.7%
|
|
GE
|
Industrials |
Morgan StanleyB |
Upgrade
|
Equal Weight
→
Overweight
|
—
|
$304.4B
|
$56.61
|
+3.2%
|
+3.5%
|
-0.5%
|
-2.3%
|
+2.5%
|
+10.3%
|
|
MRK
|
Healthcare |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$286.5B
|
$85.48
|
+0.0%
|
-1.2%
|
-2.9%
|
+0.1%
|
+0.2%
|
+1.2%
|
|
TXN
|
Technology |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$276.0B
|
$133.34
|
-1.4%
|
+0.7%
|
-2.8%
|
-3.2%
|
+1.4%
|
-2.0%
|
|
TXN
|
Technology |
Mizuho |
Maintains
|
Neutral
→
Neutral
|
—
|
$276.0B
|
$133.34
|
-1.4%
|
+0.7%
|
-2.8%
|
-3.2%
|
+1.4%
|
-2.0%
|
|
TXN
|
Technology |
Nomura |
Maintains
|
Neutral
→
Neutral
|
—
|
$276.0B
|
$133.34
|
-1.4%
|
+0.7%
|
-2.8%
|
-3.2%
|
+1.4%
|
-2.0%
|
|
TXN
|
Technology |
Stifel |
Maintains
|
Hold
→
Hold
|
—
|
$276.0B
|
$133.34
|
-1.4%
|
+0.7%
|
-2.8%
|
-3.2%
|
+1.4%
|
-2.0%
|
|
TXN
|
Technology |
Baird |
Maintains
|
Neutral
→
Neutral
|
—
|
$276.0B
|
$133.34
|
-1.4%
|
+0.7%
|
-2.8%
|
-3.2%
|
+1.4%
|
-2.0%
|